FDA
-
-
-
-
-
-
-
Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Compass Pathways (CMPS)
-
-
-
-
-
-
-
Compass Pathways to supply psilocybin for VA veteran depression trial
-
-
-
-
-
-
-
Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026
-
-
-
-
-
-
-
Oppenheimer on Compass Pathways (CMPS): 'Reinforced Durability Strengthens Launch Prospects'
-
-
-
-
-
-
-
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
-
-
-
-
-
-
-
Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026
-
334,273 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


